Cargando…
Long-term lithium therapy and risk of chronic kidney disease, hyperparathyroidism and hypercalcemia: a cohort study
BACKGROUND: Lithium is well recognized as the first-line maintenance treatment for bipolar disorder (BD). However, besides therapeutic benefits attributed to lithium therapy, the associated side effects including endocrinological and renal disorders constitute important parameters in prescribing pat...
Autores principales: | Boivin, Elise, Le Daré, Brendan, Bellay, Romain, Vigneau, Cécile, Mercerolle, Marion, Bacle, Astrid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884717/ https://www.ncbi.nlm.nih.gov/pubmed/36709463 http://dx.doi.org/10.1186/s40345-023-00286-8 |
Ejemplares similares
-
Lithium-induced Hyperparathyroidism and Hypercalcemia
por: Naramala, Srikanth, et al.
Publicado: (2019) -
Thyroid substitution may be a risk factor for Covid-19
por: Bacle, Astrid, et al.
Publicado: (2021) -
Increasing vaccine supply with low dead-volume syringes and needles
por: Le Daré, Brendan, et al.
Publicado: (2021) -
Erratum to ‘Increasing vaccine supply with low dead-volume syringes and needles’ [Int. J. Pharmaceut. 608 (2021) 121053]
por: Le Daré, Brendan, et al.
Publicado: (2022) -
SAT-359 Hypercalcemia - Is This Sarcoidosis, Hyperparathyroidism, or Both?
por: Veeramachaneni, Ravali, et al.
Publicado: (2020)